Comparison of Bone-patellar Tendon-bone and Patellar Tendon-bone Grafts in ACL Reconstruction
Comparison of Morbidity and Functional Outcomes After Anterior Cruciate Ligament Reconstruction With Bone-Tendon-Bone Graft Versus Patellar Tendon Graft Without Patellar Bone Plug in Competitive Athletes
1 other identifier
interventional
110
1 country
1
Brief Summary
The purpose of this randomized study is to compare donor site morbidity and clinical and functional outcomes of both surgery techniques (bone-patellar tendon-bone (BPTB) graft versus bone-patellar tendon without patellar bone plug (PT) graft) for anterior cruciate ligament reconstruction (ACLR) in athletes. The main questions it aims to answer are:
- Does PT graft reduce donor site morbidity compared to the standard BPTB graft?
- Does PT technique provide clinical and functional results comparable to the BPTB technique? Researchers will compare the incidence of complications and clinical and functional outcomes between the BPTB and PT grafts groups. Patients will:
- Undergo ACLR surgical intervention using one of the two assigned techniques (BPTB or PT)
- Follow a two-year assessment program, including visits at three, eight, 12 and 24 months after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2028
March 23, 2026
March 1, 2026
1.2 years
March 11, 2026
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Donor Site Morbidity
Anterior Cruciate Ligament Donor-site Morbidity Questionnaire will be used to evaluate complications at the harvest site. Scores range from 0 to 100 points, where higher scores indicates better ouctome (absence of donor-site complications).
At 3, 8, 12 and 24 months after surgery
Secondary Outcomes (19)
Function and activity level
Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Subjective knee status
Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Psychological readiness
Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Joint Awareness
Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Patient-reported symptoms
Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
- +14 more secondary outcomes
Study Arms (2)
Patellar tendon - Bone (PT)
ACTIVE COMPARATORBone - Patellar tendon - Bone (BPTB)
ACTIVE COMPARATORInterventions
After an arthroscopic examination via an anterolateral viewing portal to confirm the ACL injury, two additional portals will be established: an accessory medial portal slightly above the joint line (approximately 2cm from the medial border of the patellar tendon) and a high anteromedial portal. Once associated lesions are addressed, the graft is harvested through a 6cm longitudinal midline incision. Following paratenon dissection, the patellar tendon dimensions are measured: * Minimum length: 42mm * Width-based harvesting: if the tendon width is \<30mm, a graft consisting of one-third of the total width is harvested. If the width exceeds 30mm, a 10mm wide graft is obtained. * Bone plugs: patellar and tibial bone plugs (10x20x8mm) are harvested. While the graft is prepared, anatomic tunnels are created. The graft is secured with MectaScrew (MEDACTA) interference screws. Once fixed, an extra-articular tenodesis is performed using Arnold \& Coker technique.
After an arthroscopic examination via an anterolateral viewing portal to confirm the ACL injury, two additional portals will be established: an accessory medial portal slightly above the joint line (approximately 2cm from the medial border of the patellar tendon) and a high anteromedial portal. Once associated lesions are addressed, the graft is harvested through a 6cm longitudinal midline incision. Following paratenon dissection, the patellar tendon dimensions are measured: * Minimum length: 42mm * Width-based harvesting: if the tendon width is \<30mm, a graft consisting of one-third of the total width is harvested. If the width exceeds 30mm, a 10mm wide graft is obtained. * Bone plugs: a tibial bone plug (10x20x8mm) is harvested. While the graft is prepared, anatomic tunnels are created. The graft is secured with MectaScrew (MEDACTA) interference screws. Once fixed, an extra-articular tenodesis is performed using Arnold \& Coker technique.
Eligibility Criteria
You may qualify if:
- Time for injury to surgery of less than six months.
- Active athletes (federated or recreational)
- Patellar tendon length \> 42mm measured by MRI.
- Age between 12 and 40 years old
- Genders eligible for Study: both
You may not qualify if:
- Previous surgery or history of ligamentous knee injuries.
- Concomitant knee ligament injury
- Major meniscal injury (more than 50% of the lateral or medial meniscus)
- Chondral injury greater than Outerbridge Grade I-II
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Sciences Faculty, University of Granada
Granada, Granada, 18016, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Manuel Arroyo-Morales
Universidad de Granada
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MsC, PT
Study Record Dates
First Submitted
March 11, 2026
First Posted
March 16, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2028
Last Updated
March 23, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share